Saimaa Generics Private Limited

Saimaa Generics Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U24230WB2002PTC094308 Incorporated 28 February 2002 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma
Revenue · FY 2025
₹9.18 Cr
▲ 29% YoY
Net profit · FY 2025
₹29.91 Lakh
Net margin 3.3%
EBITDA · FY 2025
₹47.93 Lakh
EBITDA margin 5.2%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹33.73 Lakh
Issued & subscribed
Satisfied charges
₹1.75 Cr
No open charges
Company age
24 yrs
Est. 2002
Directors on board
2
As per MCA filings

About Saimaa Generics Private Limited

Data last updated:

Saimaa Generics Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 February 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24230WB2002PTC094308. Its GSTIN is 19AAGCS7418H1Z1 (West Bengal).

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹33.73 Lakh. It is led by directors Naveen Khanna and Ritu Khanna.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 756A Block P New Alipore, Kolkata, West Bengal, India – 700053.

As per the financials filed for FY 2025, the company reported a revenue of ₹9.18 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹29.91 Lakh (net margin 3.3%) and EBITDA of ₹47.93 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 5% over five years.

As per MCA filings, the company has satisfied charges of ₹1.75 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230WB2002PTC094308
Registration Number 094308
Incorporation Date 28 February 2002
ROC Kolkata
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

CIN history

Saimaa Generics has one previous CIN (Corporate Identification Number): U99999WB2002PTC094308. The current CIN is U24230WB2002PTC094308, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230WB2002PTC094308Current
U99999WB2002PTC094308Previous

Contact details

Saimaa Generics Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address is in the company report.

  • Email
  • Registered Address
    756A Block P New Alipore, Kolkata, West Bengal, India – 700053
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Saimaa Generics Private Limited, buy the company report.

Comprehensive company report
Saimaa Generics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Saimaa Generics is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Saimaa Generics Private Limited, buy the company report.

Financials of Saimaa Generics Private Limited

FY 2025 filings available

Saimaa Generics Private Limited reported revenue of ₹9.18 Cr (up 29% YoY) for FY 2025.

Revenue · FY 2025
₹9.18 Cr ▲ 29%
Net profit · FY 2025
₹29.91 Lakh margin 3.3%
EBITDA · FY 2025
₹47.93 Lakh margin 5.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 10%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 11%
5 years · compounded
▲ 4%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 29% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹47.93 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹29.91 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.2%
Net Profit Margin3.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Saimaa Generics Private Limited, buy the company report.

Board of directors of Saimaa Generics Private Limited

Saimaa Generics has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Naveen KhannaDirector28 Feb 200224 Years 8 MonthsCurrent
Ritu KhannaDirector28 Feb 200224 Years 8 MonthsCurrent

Peer comparison

Saimaa Generics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Kemsolvs Solutions Private Limited₹9.21 Cr (FY 2025)435.0%Thane, Maharashtra, India
Winmax Healthcare Private Limited₹9.2 Cr (FY 2025)0.0%Panipat, Haryana, India
Saimaa Generics Private Limitedthis company₹9.18 Cr (FY 2025)₹29.91 Lakh3.3%29.0%Kolkata, West Bengal, India
Zeneeka Healthcare Private Limited₹9.15 Cr (FY 2025)27.0%Panchkula, Haryana, India
Vetbiochem India Private Limited₹9.14 Cr (FY 2025)20.0%Pune, Maharashtra, India
Medi-Access Solutions Private Limited₹9.11 Cr (FY 2024)-13.0%New Delhi, Delhi, India

To see the full peer comparison of Saimaa Generics Private Limited, buy the company report.

Auditor

Saimaa Generics Private Limited is audited by M JAIN & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
M JAIN & ASSOCIATESFY 2019311144E

Shareholding

The shareholding of Saimaa Generics Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Saimaa Generics Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹1.75 Cr
Breakdown by lending institutions
Union Bank of India₹1.75 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Jan 200710034312Union Bank of India₹90 LakhSatisfied
10 Feb 200390245987Union Bank of India₹85 LakhSatisfied

To see the full charge records of Saimaa Generics Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Saimaa Generics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Saimaa Generics has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AAGCS7418H1Z1West BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Saimaa Generics Private Limited, buy the company report.

Recent activity

Saimaa Generics Private Limited has 3 board changes on record since 2002: 2 appointments and 1 cessation. The latest: Rabindra Nath Khanna ceased to be Director on 06 Oct 2022.

AGM
Saimaa Generics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Saimaa Generics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Ceased
Rabindra Nath Khanna ceased to be Director.
Charges
A charge registered on 10 Feb 2003 via Charge ID 90245987 with Union Bank Of India was fully satisfied on 22 Feb 2022.
Charges
A charge registered on 15 Jan 2007 via Charge ID 10034312 with Union Bank Of India was fully satisfied on 19 Aug 2011.
Charges
A charge with Union Bank Of India of Rs. 90.00 Lakh registered on 15 Jan 2007 with Charge ID 10034312 was modified on 31 Jan 2008.
Charges
A charge with Union Bank Of India amounted to Rs. 90.00 Lakh with Charge ID 10034312 was registered on 15 Jan 2007.
Charges
A charge with Union Bank Of India of Rs. 85.00 Lakh registered on 10 Feb 2003 with Charge ID 90245987 was modified on 09 Feb 2005.
Charges
A charge with Union Bank Of India amounted to Rs. 85.00 Lakh with Charge ID 90245987 was registered on 10 Feb 2003.
Appointed
Naveen Khanna was appointed as Director.
Appointed
Ritu Khanna was appointed as Director.
Incorporation
28 Feb 2002
Saimaa Generics Private Limited was registered on 28 Feb 2002 with Roc Kolkata & aged 24 years 8 months as per MCA records.

Frequently asked questions

Saimaa Generics is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 February 2002 (24+ years old) and is registered under CIN U24230WB2002PTC094308.

Saimaa Generics has 2 current directors:

The latest financial statements of Saimaa Generics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Saimaa Generics is 19AAGCS7418H1Z1, registered in West Bengal.

The CIN (Corporate Identification Number) of Saimaa Generics is U24230WB2002PTC094308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Saimaa Generics has 1 court case on record: 1 filed by the company.

Saimaa Generics was incorporated on 28 February 2002, making it 24+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Saimaa Generics by revenue are Kemsolvs Solutions Private Limited, Winmax Healthcare Private Limited, Zeneeka Healthcare Private Limited, Vetbiochem India Private Limited, Medi-Access Solutions Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Rabindra Nath Khanna ceased to be Director on 06 Oct 2022. Naveen Khanna was appointed as Director on 28 Feb 2002. Ritu Khanna was appointed as Director on 28 Feb 2002.

The registered office of Saimaa Generics is at 756A Block P New Alipore, Kolkata, West Bengal, India – 700053.

Saimaa Generics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.